A Double Blind, Placebo Controlled Clinical Trial on Hospitalized Covid Patients using Informed Water

Abstract

Two technological hurdles need to be overcome for biofield therapies to transition fromfringe status to active clinical application. First, healing intention must be able to bestored, and second, it must be able to be scaled. Work on the storage problem has beendone for some decades, but the scalability problem has rarely been addressed. The presentstudy evaluates the therapeutic effect of “informed water” on West African patientsentering a hospital for Covid. One hundred sixty patients were randomly assigned toeither a treatment or control group. Both groups were blindly administered sublingualdrops of water over the course of a week. The two water formulations given sublinguallyto the treatment group went through a physical device designed to capture and reproducethe healing phenomenon. The control group was administered sublingual dropsof untreated water. Multiple Covid symptoms were measured daily over the course ofa week. In addition, multiple PCR tests were administered. The patients receiving theinformed water were blindly assessed to have significant improvements on a numberof symptoms, and those patients also reported higher levels of general health and fewerpositive PCR results. The data from this experiment are strongly suggestive that 1)water is a good medium for the storage of healing; 2) the therapeutically prepared informedwater can be replicated by a physical device and is hence scalable; 3) mass-producedwater can deliver a strong therapeutic effect on Covid; 4) there are no negativeside effects. Future work on additional health conditions needs to be carried out.